Clascoterone cream for rosacea bumps and pimples
Part of Skin clinical trials.
This study tests a cream called clascoterone (already approved for acne) to see if it can help treat facial rosacea that causes bumps and pimples. Participants will use the cream daily and attend regular check-ups to see if their skin improves.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with papulopustular rosacea (the kind with bumps and pimples on your face).
- You are willing to use the same facial and hair products (like makeup, shampoo, etc.) for the whole study.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You are not allergic to the study cream or its ingredients.
- You are not currently in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called remibrutinib (taken as a pill) to see if it can safely reduce the redness and bumps caused by papulopustular rosacea. It is for people with moderate to severe symptoms who have not had success with other treatments.
This trial tests a cream applied to the skin to treat pilonidal sinus disease, a painful skin condition in the crease of the buttocks. The goal is to see if it can help reduce symptoms and improve healing.
This trial tests a new cream called clascoterone for moderate to severe facial acne. It may help reduce pimples and blackheads with fewer side effects than some other treatments.
This study tests a new cream (clascoterone) for moderate to severe acne. The cream is applied to the face to reduce pimples and is compared to a placebo (a cream without the active ingredient).
This trial compares two topical creams, clascoterone and adapalene, to see which works better for mild acne. If you have mild acne and are between 12 and 35, you might be able to join.
This study tests a special cream to reduce facial redness caused by rosacea, either alone or combined with laser treatment. It aims to help people with persistent redness and visible blood vessels on their face.
Hear when a new Papular-pustular Rosacea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.